
Dr. Blasi completed her undergraduate and Ph.D. studies in Italy at the Sapienza University in Rome. She moved to Duke in 2012 for a postdoctoral position in Mary Klotman’s laboratory at the Duke Human Vaccine Institute (DHVI).
The Blasi laboratory has two main areas of research: 1) understanding the mechanisms and implications of viral infections in the kidney, including HIV and SARS-CoV-2 and 2) development of vaccines and therapeutics against a variety of infectious diseases.
Dr. Blasi is also the co-director of the DHVI training mentoring program (DTMP). The DTMP is committed to providing an outstanding training environment and research experiences that will enhance trainees career and provide avenues to incorporate education, expertise, initiative and dedication to the success of the studies.
Education and Training
- Ph.D., La Sapienza University of Rome (Italy), 2012
Grants
- Understanding the interplay between local viral infection and local inflammation in COVID-19 kidney injury (R01)
- Recombinant vectored delivery of maternal antibody for transfer into breast milk and across the placenta
- Targeting the HIV-1 reservoir with a combination of an IDLV-SIVGag therapeutic vaccine and Fc-engineered bnAbs (R01)